about
Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements.Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173LThe i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fissionImbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in miceThe Mitochondrial Metallochaperone SCO1 Is Required to Sustain Expression of the High-Affinity Copper Transporter CTR1 and Preserve Copper HomeostasisLRPPRC and SLIRP interact in a ribonucleoprotein complex that regulates posttranscriptional gene expression in mitochondria.The role of mitochondrial DNA copy number in mammalian fertility.Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria.Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms.Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism.The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes.Stomatin-like protein 2 is required for in vivo mitochondrial respiratory chain supercomplex formation and optimal cell function.SLIRP Regulates the Rate of Mitochondrial Protein Synthesis and Protects LRPPRC from Degradation.Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission.Mitochondrial DNA and the mammalian oocyte.Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.Mitochondrial Dynamics and Metabolic Regulation.Medicine. Sidestepping mutational meltdown.The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L.A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy
P50
Q24539565-EA0F279B-B08A-44F3-8BDE-443FB54B9C62Q24632653-C4A1B6F7-20A7-44AF-9403-9A7EC5C0CC35Q28235694-C741D59E-1360-4B81-8D5B-8C61263468F7Q28272272-4F9F37A2-8D2A-4BFA-87B1-93E6C8FE0260Q28591894-875F2445-AB8A-4A8E-AECA-6A854EC2E447Q33787234-F94FE63C-F474-4EBB-9CB8-8EE28B685324Q33926626-E58A0DCA-9DA6-4437-9403-5E7172CA8C57Q34163250-74A8201D-5786-43C1-A4CE-827597CCDE12Q34171522-897FFC33-34E4-459A-B270-5BBF6653951FQ34364768-0DF302AB-7475-4400-9D19-0B5E15AA47D6Q34887679-906CFF78-6283-4D1F-909F-1267A67DD75AQ35516613-24319CA4-32E7-4292-8508-1870BF6CEA1FQ35738774-1C2ACFC3-2C4F-4375-87A0-AEB17032D305Q36382138-6A1C333B-BA55-4945-B6AD-6F9043819640Q36707790-E0AA51E4-2C0A-418E-B9B9-843F1FBE230BQ38181036-E370B9EA-584D-4A0F-8592-26BD8CA7F60FQ38692748-706E8F83-3E24-4A7C-B42F-3F4E3ECE87B7Q40012864-533D188C-0271-474E-A286-D25A65C9AB1DQ45161551-3ADFC99F-B13C-48F9-BF53-5F8ADCB174F0Q56856177-76B89AEE-C9EA-4F3E-AEA0-299D2ECA87F3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Timothy Wai
@en
Timothy Wai
@es
Timothy Wai
@nl
Timothy Wai
@sl
type
label
Timothy Wai
@en
Timothy Wai
@es
Timothy Wai
@nl
Timothy Wai
@sl
prefLabel
Timothy Wai
@en
Timothy Wai
@es
Timothy Wai
@nl
Timothy Wai
@sl
P106
P21
P31
P496
0000-0002-6770-6222